Filing Flows › Ceribell (CBLL) › Recalls, complaints & regulation
Ceribell (CBLL): clinical trials
Ceribell (CBLL) beyond its filings: 3 active clinical trials.
Ceribell's latest quarter
Ceribell, Q3 2026: revenue $29.3M (+30% year over year), operating margin -70.0%, net loss $21.4M, operating cash flow −$13.1M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Ceribell have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.